Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Panagiotis Gklinos
Observed names:
Gklinos Panagiotis,
Παναγιώτης Γκλίνος
Institutions:
Queen Mary University of London,
National and Kapodistrian University of Athens,
Eginition Hospital
Observed institutions:
Queen Mary University of London,
National and Kapodistrian University of Athens,
Barts Health NHS Trust,
Royal London Hospital,
Eginition Hospital,
KAT General Hospital of Attica
show all 6
ORCID:
0000-0001-5022-6460
Observed ORCID:
0000-0001-5022-6460
OpenAlex ID:
A5034272707
Monoclonal Antibodies as Neurological Therapeutics
2021
·
Panagiotis Gklinos
, Miranta Papadopoulou
, et al.
·
Pharmaceuticals
·
72
PDF
Neurological manifestations of COVID-19: a review of what we know so far
2020
·
Panagiotis Gklinos
·
Journal of Neurology
·
42
PDF
Myelin Oligodendrocyte Glycoprotein-Antibody Associated Disease: An Updated Review of the Clinical Spectrum, Pathogenetic Mechanisms and Therapeutic Management
2024
·
Panagiotis Gklinos
, Ruth Dobson
·
Antibodies
·
37
PDF
Galcanezumab in migraine prevention: a systematic review and meta-analysis of randomized controlled trials
2020
·
Panagiotis Gklinos
, Dimos D. Mitsikostas
·
Therapeutic Advances in Neurological Disorders
·
35
Unveiling GFAP Astrocytopathy: Insights from Case Studies and a Comprehensive Review of the Literature
2024
·
Panagiotis Gklinos
, Fotios Athanasopoulos
, et al.
·
Antibodies
·
27
PDF
Monoclonal Antibodies in Pregnancy and Breastfeeding in Patients with Multiple Sclerosis: A Review and an Updated Clinical Guide
2023
·
Panagiotis Gklinos
, Ruth Dobson
·
Pharmaceuticals
·
20
PDF
Headache disorders in multiple sclerosis: Is there an association? A systematic review and meta-analysis
2024
·
Panagiotis Gklinos
, Dimos-Dimitrios Mitsikostas
·
Multiple Sclerosis and Related Disorders
·
13
Migraine in multiple sclerosis patients: potential links and treatment approach
2023
·
Panagiotis Gklinos
, Dimos-Dimitrios Mitsikostas
·
Expert Opinion on Pharmacotherapy
·
12
Nocebo in multiple sclerosis trials: A meta-analysis on oral and newer injectable disease-modifying treatments
2019
·
Panagiotis Gklinos
, Dimitrios Papadopoulos
, et al.
·
Multiple Sclerosis and Related Disorders
·
10
Chronic Pain in Multiple Sclerosis: Mechanisms, Clinical Characteristics and Treatment Strategies
2026
·
Panagiotis Gklinos
, Georgia Christodoulou
, et al.
·
International Journal of Molecular Sciences
·
8
PDF
The Role of Galcanezumab in Migraine Prevention: Existing Data and Future Directions
2021
·
Panagiotis Gklinos
, Dimos Mitsikostas
·
Pharmaceuticals
·
8
PDF
Association between multiple sclerosis lesion location, migraine and tension-type headache: A cross-sectional study
2025
·
Panagiotis Gklinos
, Maria-Eleftheria Evangelopoulos
, et al.
·
Journal of Clinical Neuroscience
·
7
Migraine and Tension-Type Headache Are Associated with Multiple Sclerosis: A Case–Control Study
2025
·
Panagiotis Gklinos
, Maria-Eleftheria Evangelopoulos
, et al.
·
Journal of Clinical Medicine
·
7
PDF
Migraine and tension-type headache in multiple sclerosis: A two-year, prospective, longitudinal, controlled study
2025
·
Panagiotis Gklinos
, Maria-Eleftheria Evangelopoulos
, et al.
·
Multiple Sclerosis and Related Disorders
·
6
Disease-modifying treatments for multiple sclerosis have not affected the incidence of neoplasms in clinical trials over 3 decades: a meta-analysis with meta-regression
2022
·
Dimitrios Papadopoulos
, Panagiotis Gklinos
, et al.
·
Journal of Neurology
·
6
Neurological Manifestations of Hyperosmolar Hyperglycemic State: A Case Report and A Review of the Literature
2023
·
Panagiotis Gklinos
·
SVOA Neurology
·
3
PDF
Fatigue-associated variables in multiple sclerosis and affective drug treatment
2025
·
Panagiotis Gklinos
, Dimos D. Mitsikostas
·
Elsevier eBooks
·
1
Menopause in women with multiple sclerosis: clinical symptoms, therapeutic considerations and possible impact on the course of the disease
2023
·
Panagiotis Gklinos
, Ruth Dobson
·
British Journal of Neuroscience Nursing
·
1
Exercise in Multiple Sclerosis: Mechanisms, Clinical Benefits, Potential Disease-Modifying Effects, and Practical Recommendations
2026
·
Panagiotis Gklinos
, Georgia Christodoulou
, et al.
·
International Journal of Molecular Sciences
Availability of resources to apply the 2024 McDonald criteria: A global perspective
2026
·
Natalia Gómez-Salazar
, Paola A. Ortíz-Salas
, et al.
·
Multiple Sclerosis Journal
Evaluating the feasibility of a remote sampling method for neurofilament light chain measurements in Multiple Sclerosis
2026
·
Panagiotis Gklinos
, Nicola Vickaryous
, et al.
·
Multiple Sclerosis and Related Disorders
Motor neuron disease can present as a paraneoplastic neurologic syndrome with various phenotypes
2026
·
Eleftheria Koropouli
, Stavros Bellos
, et al.
·
Brain Communications
Migraine and other headache disorders in patients with multiple sclerosis: a prospective cohort study
2025
·
Παναγιώτης Γκλίνος
Pearls & Oy-sters: Late-Onset Presumed SUNA in a 91-Year-Old Woman With Headache
2025
·
Panagiotis Gklinos
·
Neurology
片頭痛予防におけるガルカネズマブ: 無作為化対照試験の系統的レビューとメタ分析【jst・京大機械翻訳】
2020
·
Gklinos Panagiotis
, D Mitsikostas Dimos
·
Therapeutic Advances in Neurological Disorders
Show more works
View as search
Works count:
26
Citation count:
315
H-index:
9
I10-index:
9
Year
Topic
Type